White label ELPA - ClinicalTrials.eu

Study on Niraparib’s Effects and Safety in Patients with High-Grade Serous Ovarian Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Ovarian epithelial cancer
Investigated drugs:
- Niraparib Tosilate Monohydrate
Study of G1XCGD Lentiviral Vector in Patients with X-Linked Chronic Granulomatous Disease

Not recruiting

2 1 1
Investigated diseases:
- Chronic granulomatous disease
Investigated drugs:
- Autologous Cd34+ Cells Transduced With The G1Xcgd Lentiviral Vector Containing The Human Cybb Gene
Study Comparing Aliskiren and Enalapril for Patients with C3 Glomerulopathy

Not recruiting

2 1 1 1
Investigated diseases:
- C3 glomerulopathy
Investigated drugs:
- Aliskiren
- Enalapril Maleate
Study on the Safety and Effectiveness of NMD670 for Adults with Charcot-Marie-Tooth Disease Types 1 and 2

Not recruiting

2 1
Investigated diseases:
- Hereditary motor and sensory neuropathy
Investigated drugs:
- Nmd670
Study on the Safety and Effects of Vimseltinib for Patients with Advanced Tumors and Tenosynovial Giant Cell Tumor

Not recruiting

2 1 1
Investigated diseases:
- Neoplasm malignant
Investigated drugs:
- Vimseltinib
Study on the Safety and Effectiveness of Diamyd and Colecalciferol for Adolescents and Adults with Recently Diagnosed Type 1 Diabetes

Not recruiting

3 1 1
Investigated diseases:
- Type 1 diabetes mellitus
Investigated drugs:
- Colecalciferol
- Glutamate Decarboxylase 2, Human, Recombinant
+2
Study on the Long-Term Safety and Effectiveness of Filgotinib for Patients with Rheumatoid Arthritis

Not recruiting

3 1 1 1
Investigated diseases:
- Rheumatoid arthritis
Investigated drugs:
- Filgotinib
Study Comparing Adagrasib and Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Adagrasib
- Docetaxel
+8
Study on Inclisiran and Statin Therapy for Patients with Non-obstructive Coronary Artery Disease to Assess Atherosclerotic Plaque Progression

Not recruiting

3 1 1
Investigated diseases:
- Coronary artery disease
Investigated drugs:
Study on Caplacizumab and Immunosuppressive Therapy for Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura

Not recruiting

3 1 1 1
Investigated diseases:
- Thrombotic thrombocytopenic purpura
Investigated drugs:
- Caplacizumab
+3

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies